142 related articles for article (PubMed ID: 25706284)
21. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction.
García JR; Jaumann F; Schulz S; Krause A; Rodríguez-Jiménez J; Forssmann U; Adermann K; Klüver E; Vogelmeier C; Becker D; Hedrich R; Forssmann WG; Bals R
Cell Tissue Res; 2001 Nov; 306(2):257-64. PubMed ID: 11702237
[TBL] [Abstract][Full Text] [Related]
22. Introduction of human β-defensin-3 into cultured human keratinocytes and fibroblasts by infection of a recombinant adenovirus vector.
Suzuki Y; Inokuchi S; Takazawa K; Umezawa K; Saito T; Kidokoro M; Tanaka M; Matsuzawa H; Inoue S; Tuchiya I; Ando K
Burns; 2011 Feb; 37(1):109-16. PubMed ID: 20884123
[TBL] [Abstract][Full Text] [Related]
23. Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice.
Yamaguchi Y; Nagase T; Makita R; Fukuhara S; Tomita T; Tominaga T; Kurihara H; Ouchi Y
J Immunol; 2002 Sep; 169(5):2516-23. PubMed ID: 12193721
[TBL] [Abstract][Full Text] [Related]
24. Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3.
Hinrichsen K; Podschun R; Schubert S; Schröder JM; Harder J; Proksch E
Antimicrob Agents Chemother; 2008 May; 52(5):1876-9. PubMed ID: 18332171
[TBL] [Abstract][Full Text] [Related]
25. Human beta-defensin-3: a promising antimicrobial peptide.
Batoni G; Maisetta G; Esin S; Campa M
Mini Rev Med Chem; 2006 Oct; 6(10):1063-73. PubMed ID: 17073706
[TBL] [Abstract][Full Text] [Related]
26. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.
Joly S; Maze C; McCray PB; Guthmiller JM
J Clin Microbiol; 2004 Mar; 42(3):1024-9. PubMed ID: 15004048
[TBL] [Abstract][Full Text] [Related]
27. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1.
Schroeder BO; Wu Z; Nuding S; Groscurth S; Marcinowski M; Beisner J; Buchner J; Schaller M; Stange EF; Wehkamp J
Nature; 2011 Jan; 469(7330):419-23. PubMed ID: 21248850
[TBL] [Abstract][Full Text] [Related]
28. Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines.
Scudiero O; Galdiero S; Nigro E; Del Vecchio L; Di Noto R; Cantisani M; Colavita I; Galdiero M; Cassiman JJ; Daniele A; Pedone C; Salvatore F
Antimicrob Agents Chemother; 2013 Apr; 57(4):1701-8. PubMed ID: 23357761
[TBL] [Abstract][Full Text] [Related]
29. Oral streptococci exhibit diverse susceptibility to human beta-defensin-2: antimicrobial effects of hBD-2 on oral streptococci.
Nishimura E; Eto A; Kato M; Hashizume S; Imai S; Nisizawa T; Hanada N
Curr Microbiol; 2004 Feb; 48(2):85-7. PubMed ID: 15057473
[TBL] [Abstract][Full Text] [Related]
30. Effect of preservative-free artificial tears on the antimicrobial activity of human beta-defensin-2 and cathelicidin LL-37 in vitro.
Huang LC; Jean D; McDermott AM
Eye Contact Lens; 2005 Jan; 31(1):34-8. PubMed ID: 15665670
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial properties of human beta defensin-3 derivative: CHRG01.
Arora A; Majhi S; Mishra A
J Biosci; 2018 Sep; 43(4):707-715. PubMed ID: 30207316
[TBL] [Abstract][Full Text] [Related]
32. Effect of ions on antibacterial activity of human beta defensin 2.
Tomita T; Hitomi S; Nagase T; Matsui H; Matsuse T; Kimura S; Ouchi Y
Microbiol Immunol; 2000; 44(9):749-54. PubMed ID: 11092238
[TBL] [Abstract][Full Text] [Related]
33. A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts.
Nuding S; Fellermann K; Wehkamp J; Mueller HA; Stange EF
J Microbiol Methods; 2006 May; 65(2):335-45. PubMed ID: 16182394
[TBL] [Abstract][Full Text] [Related]
34. A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo.
Huang GT; Zhang HB; Kim D; Liu L; Ganz T
Hum Gene Ther; 2002 Nov; 13(17):2017-25. PubMed ID: 12489997
[TBL] [Abstract][Full Text] [Related]
35. Expression and activity of beta-defensins and LL-37 in the developing human lung.
Starner TD; Agerberth B; Gudmundsson GH; McCray PB
J Immunol; 2005 Feb; 174(3):1608-15. PubMed ID: 15661923
[TBL] [Abstract][Full Text] [Related]
36. In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains.
Maisetta G; Batoni G; Esin S; Florio W; Bottai D; Favilli F; Campa M
Antimicrob Agents Chemother; 2006 Feb; 50(2):806-9. PubMed ID: 16436752
[TBL] [Abstract][Full Text] [Related]
37. N-Terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine β-defensin-2 results in salt-resistant antibacterial activity.
Krishnakumari V; Nagaraj R
Biophys Chem; 2015 Apr; 199():25-33. PubMed ID: 25791057
[TBL] [Abstract][Full Text] [Related]
38. Human beta-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication.
Zucht HD; Grabowsky J; Schrader M; Liepke C; Jürgens M; Schulz-Knappe P; Forssmann WG
Eur J Med Res; 1998 Jul; 3(7):315-23. PubMed ID: 9682027
[TBL] [Abstract][Full Text] [Related]
39. Human-β-defensins-1-3 and analogs do not require proton motive force for antibacterial activity against Escherichia coli.
Krishnakumari V; Packiyanathan KK; Nagaraj R
FEMS Microbiol Lett; 2013 Nov; 348(1):52-7. PubMed ID: 23980689
[TBL] [Abstract][Full Text] [Related]
40. Human defensins.
Schneider JJ; Unholzer A; Schaller M; Schäfer-Korting M; Korting HC
J Mol Med (Berl); 2005 Aug; 83(8):587-95. PubMed ID: 15821901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
